申请人:Vertex Pharmaceuticals Incorporated
公开号:EP3527563A1
公开(公告)日:2019-08-21
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
本发明涉及可用作 DNA-PK 抑制剂的化合物。本发明还提供了包含所述化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病、病症或失调的方法。